erythrosine has been researched along with Myeloproliferative Disorders in 1 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teofili, L | 1 |
| Martini, M | 1 |
| Iachininoto, MG | 1 |
| Capodimonti, S | 1 |
| Nuzzolo, ER | 1 |
| Torti, L | 1 |
| Cenci, T | 1 |
| Larocca, LM | 1 |
| Leone, G | 1 |
1 other study available for erythrosine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms.
Topics: Adult; Aged; Amino Acid Substitution; Biomarkers; Cell Adhesion; Cell Proliferation; Cell Separation | 2011 |